Related Experiment Videos
Receptor-ligand interaction between CD44 and osteopontin (Eta-1)
G F Weber1, S Ashkar, M J Glimcher
1Dana-Farber Cancer Institute, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
Science (New York, N.Y.)
|January 26, 1996
Summary
The CD44 receptor binds to osteopontin and hyaluronate, influencing cell movement and growth differently. This interaction is crucial for cell functions and may drive tumor metastasis.
Area of Science:
- Cell biology
- Molecular biology
- Cancer research
Background:
- CD44 is a cell surface receptor involved in cell adhesion, migration, and activation.
- Osteopontin (Eta-1) is a cytokine that regulates similar cellular functions.
- CD44 and osteopontin interactions are critical in normal and neoplastic cell behavior.
Purpose of the Study:
- To investigate the role of osteopontin as a ligand for CD44.
- To understand how CD44 ligation by different ligands affects cellular functions.
- To explore the implications of these interactions in tumor metastasis.
Main Methods:
- Investigated the binding of osteopontin to CD44.
- Compared cellular responses to CD44 ligation by osteopontin versus hyaluronate.
- Assessed effects on cell chemotaxis and homotypic aggregation.
Main Results:
- Osteopontin was identified as a protein ligand for CD44.
- Osteopontin binding induced cell chemotaxis but not aggregation.
- CD44 binding to hyaluronate induced aggregation but not chemotaxis.
- Distinct cellular responses were observed based on the CD44 ligand.
Conclusions:
- CD44 ligation by osteopontin and hyaluronate elicits differential cellular responses, affecting cell migration and growth independently.
- This mechanism may be exploited by tumor cells to promote metastasis.
- Understanding CD44-ligand interactions offers insights into cancer progression and therapeutic strategies.